Ansata Therapeutics


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Founded in early 2002 by Avalon Ventures and Domain Associates, Ansata Therapeutics is developing & commercializing novel medicines that capitalize on the Company's industry- leading expertise and intellectual property in molecular transduction. Ansata has several preclinical programs under development in the oncology and neurodegenerative disease areas. The company strives to rapidly advance lead compounds from late-stage preclinical research into clinical development by leveraging its propriet...Show all

Founded in early 2002 by Avalon Ventures and Domain Associates, Ansata Therapeutics is developing & commercializing novel medicines that capitalize on the Company's industry- leading expertise and intellectual property in molecular transduction. Ansa...Show all

Company (Alive / Active)

Phone: 858-754-3000

Fax:

505 Coast Boulevard South
La Jolla, 92037
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Ansata Therapeutics $5M Mar 24, 2003
See all 20 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Ansata Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors

Competitors

Company Status Description Investors

Trillium Therapeutics

Toronto, Ontario, Canada
IPO / Went publicTrillium Therapeutics is a research and development company developing therapies that restore balance to the immune system in conditions associated with aberrant and harmful immune responses, including autoimmune and inflammatory disorders, graft rejection, cancer and chronic viral diseases.Login to see details

Molecular Templates

Georgetown, Texas, United States
IPO / Went publicMolecular Templates is a biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapeutics with advantages over existing Antibody Drug Conjugates (ADCs). This biologics platform technology can be used to develop different therapies across a wide range of cancers.Login to see details
See all 20 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)